Adlercreutzia equolifaciens is an anaerobe, mesophilic, Gram-positive Actinobacterium that was isolated from human faeces.
For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.
Product Information
Product Overview
Adlercreutzia equolifaciens is an anaerobe, mesophilic, Gram-positive Actinobacterium that was isolated from human faeces.
Target
Eggerthellaceae
Genus
Adlercreutzia
Strain Designation
FJC-B9
Application
Study and research
Culture Medium
Medium 339
Culture Conditions
37°C; Anaerobic
Source
Human faeces
Risk Group
1
Genbank Accession Numbers
16S rRNA gene: AB306661 complete genome: AP013105
Product Format
Freeze-dried
Packaging
Ampoule tube
Storage
-80°C
Shelf Life
6 years
Target Introduction
Introduction
The Eggerthellaceae are a family of Gram-positive, rod- or coccus-shaped Actinobacteria. It is the sole family within the order Eggerthellales. Members of this family are mostly anaerobic, non-motile, asaccharolytic and do not form spores. Eggerthellaceae species are commonly isolated from human and animal faeces and other human sources such as the colon, vagina, oral cavity and blood.
Alternative Names
Adlercreutzia equolifaciens; FJC-B9
FAQs Customer Reviews Related Products
What are the specific growth conditions required for Adlercreutzia equolifaciens; FJC-B9 in laboratory settings?
Adlercreutzia equolifaciens; FJC-B9 requires anaerobic conditions for optimal growth. The ideal temperature is 37°C, and the medium should be supplemented with necessary nutrients. Maintaining a pH range between 6.5 and 7.5 is crucial for its proliferation.
How does Adlercreutzia equolifaciens; FJC-B9 contribute to the production of equol in the human gut?
Adlercreutzia equolifaciens; FJC-B9 is used primarily in gut microbiota research, probiotic development, and studies related to hormone modulation. Its ability to produce equol makes it valuable for exploring new therapeutic strategies.
What are the primary research applications of Adlercreutzia equolifaciens; FJC-B9?
Adlercreutzia equolifaciens; FJC-B9 is used primarily in gut microbiota research, probiotic development, and studies related to hormone modulation. Its ability to produce equol makes it valuable for exploring new therapeutic strategies.
What techniques are used to isolate and identify Adlercreutzia equolifaciens; FJC-B9 in research?
Isolation of Adlercreutzia equolifaciens; FJC-B9 involves anaerobic culturing on selective media. Identification is typically performed using 16S rRNA gene sequencing to ensure accurate classification within the gut microbiota.
Exceptional Performance in Gut Microbiota Studies
The Adlercreutzia equolifaciens; FJC-B9 strain exhibits remarkable stability and growth in gut microbiota studies. Its performance surpasses other strains.
Reliable for Hormonal Modulation Research
Creative Biolabs' Adlercreutzia equolifaciens; FJC-B9 is highly reliable for hormonal modulation studies. Its consistent equol production is pivotal for developing new therapeutic strategies.
Unmatched in Gut Health Research Adlercreutzia equolifaciens; FJC-B9 offers unmatched performance in gut health research. Its stability and reproducibility make it an essential tool for researchers exploring gut microbiota.
Top Choice for Advanced Probiotic Research
Creative Biolabs' Adlercreutzia equolifaciens; FJC-B9 is the top choice for advanced probiotic research. Its superior growth rate and metabolic activity provide significant advantages over competing products.
Click the button below to contact us or submit your feedback about this product.
